Suppr超能文献

血管紧张素转换酶抑制剂与利尿剂联合应用对一氧化氮缺乏诱导的大鼠高血压模型血压及肾损伤的影响

Effects of angiotensin-converting-enzyme inhibitors in combination with diuretics on blood pressure and renal injury in nitric oxide-deficiency-induced hypertension in rats.

作者信息

García-Estañ Joaquín, Ortiz M Clara, O'Valle Francisco, Alcaraz Antonia, Navarro Esther G, Vargas Félix, Evangelista Stefano, Atucha Noemí M

机构信息

Department of Physiology, Faculty of Medicine, University of Murcia, 30100 Murcia, Spain.

出版信息

Clin Sci (Lond). 2006 Feb;110(2):227-33. doi: 10.1042/CS20050165.

Abstract

The present study investigates the effects of chronic administration of ACEIs (angiotensin-converting-enzyme inhibitors; either zofenopril or enalapril) in combination with a diruetic (hydrochlorothiazide) on BP (blood pressure) increase and renal injury induced by L-NAME (NG-nitro-L-arginine methyl ester), an inhibitor of NO (nitric oxide) synthesis. Rats were untreated or received L-NAME alone, L-NAME+zofenopril+hydrochlorothiazide or L-NAME+enalapril+hydrochlorothiazide for 8 weeks. L-NAME treatment resulted in marked elevation in BP and mortality. Treatment with either ACEI and diuretic prevented the increase in BP induced by L-NAME, reduced the death rate and improved excretory parameters. Renal injury in the L-NAME group was severe, but, in the groups treated with either ACEI and diuretic, glomerular and tubulointerstitial lesions were not observed and the intensity, number and size of vessels affected was reduced. However, the efficacy of zofenopril+diuretic was superior to that of enalapril+diuretic in reducing vascular alterations. Oxidative stress indices and the expression of NO synthase and nitrotyrosine were normalized by the treatments. In conclusion, the combined treatment of zofenopril or enalapril with hydrochlorothiazide completely prevented the development of arterial hypertension induced by L-NAME. Renal morphological and functional alterations in the hypertensive animals were also almost completely normalized, but the treatment with zofenopril+diuretic produced a more complete organ protection. The protective effect is related to an activation of endothelial NO synthase expression and to a normalization of the oxidative stress parameters due to the inhibition of angiotensin II.

摘要

本研究调查了长期给予血管紧张素转换酶抑制剂(ACEIs,即佐芬普利或依那普利)联合利尿剂(氢氯噻嗪)对L-精氨酸甲酯(L-NAME,一种一氧化氮(NO)合成抑制剂)诱导的血压升高和肾损伤的影响。大鼠未接受治疗或单独接受L-NAME、L-NAME+佐芬普利+氢氯噻嗪或L-NAME+依那普利+氢氯噻嗪治疗8周。L-NAME治疗导致血压显著升高和死亡率增加。使用任何一种ACEI和利尿剂进行治疗均可预防L-NAME诱导的血压升高,降低死亡率并改善排泄参数。L-NAME组的肾损伤严重,但在使用任何一种ACEI和利尿剂治疗的组中,未观察到肾小球和肾小管间质病变,且受影响血管的强度、数量和大小均有所减少。然而,在减少血管改变方面,佐芬普利+利尿剂的疗效优于依那普利+利尿剂。氧化应激指标以及NO合酶和硝基酪氨酸的表达通过治疗得以正常化。总之,佐芬普利或依那普利与氢氯噻嗪联合治疗可完全预防L-NAME诱导的动脉高血压的发展。高血压动物的肾脏形态和功能改变也几乎完全恢复正常,但佐芬普利+利尿剂治疗对器官的保护作用更完全。这种保护作用与内皮型NO合酶表达的激活以及由于血管紧张素II的抑制导致的氧化应激参数的正常化有关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验